AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23810050 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐viscosity light‐cured resin infiltration after enamel conditioning with a 15% HCl gel
Number of subjects: 21
Study 23810050 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 21
Study 21138531 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine (20 μg/hr, 144 hr)
Number of subjects: 22
Study 21138531 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl (25 μg/hr, 72 hr)
Number of subjects: 22
Study 21138531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 18826873 — intervention group
Group type: EXPERIMENTAL
Intervention: PITT (psychodynamically oriented inpatient treatment program)
Number of subjects: 84
Study 18826873 — intervention group
Group type: EXPERIMENTAL
Intervention: PITT
Number of subjects: 84
Study 18826873 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (treatment as usual)
Number of subjects: 84
Study 16672309 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 day food records (FRs)
Number of subjects: 1809
Study 16672309 — intervention group
Group type: COMPARATOR
Intervention: Food frequency questionnaires (FFQ)
Number of subjects: 1809
Study 14594781 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (45 min/d, 5 d/wk)
Number of subjects: 74
Study 14594781 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 74
Study 10793606 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelofusine 500 ml over 15 min
Number of subjects: 20
Study 10793606 — intervention group
Group type: COMPARATOR
Intervention: No fluid preload
Number of subjects: 20
Study 8972009 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of anticoagulation by kaolin ACT combined with on-site measurements of whole blood heparin concentration (Intervention, n = 15)
Number of subjects: 31
Study 8972009 — intervention group
Group type: COMPARATOR
Intervention: Monitoring of anticoagulation by celite ACT (Control, n = 16)
Number of subjects: 31
Study 1483820 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires with portion sizes included
Number of subjects: 6783
Study 1483820 — intervention group
Group type: COMPARATOR
Intervention: Questionnaires without portion sizes
Number of subjects: 6783
Study 1483820 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires with decreasing order of frequency categories
Number of subjects: 6783
Study 1483820 — intervention group
Group type: COMPARATOR
Intervention: Shorter basic form questionnaires
Number of subjects: 6783
Study 3993604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with thiocyanate concentration of 19 mg/l
Number of subjects: 55
Study 3993604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with thiocyanate concentration of 3.6 mg/l
Number of subjects: 55
Study 3993604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with iodine concentration of 0.1 mg/l and thiocyanate concentration of 19 mg/l
Number of subjects: 55
Study 3993604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with iodine concentration of 0.1 mg/l and thiocyanate concentration of 3.6 mg/l
Number of subjects: 55
Study 30969874 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy questionnaires (3 different tools)
Number of subjects: 108
Study 30017351 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy
Number of subjects: 326
Study 30017351 — intervention group
Group type: COMPARATOR
Intervention: Open radical retropubic prostatectomy
Number of subjects: 326
Study 26949830 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task (mental fatigue)
Number of subjects: 12
Study 26949830 — intervention group
Group type: COMPARATOR
Intervention: Reading from magazines (control)
Number of subjects: 12
Study 24877590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 106
Study 24877590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 22348423 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT plus care as usual
Number of subjects: 90
Study 22348423 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 90
Study 20059794 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention leaflet
Number of subjects: 823
Study 20059794 — intervention group
Group type: COMPARATOR
Intervention: Generic leaflet (Control)
Number of subjects: 823
Study 16918613 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol
Number of subjects: 4
Study 16918613 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 4
Study 16918613 — intervention group
Group type: COMPARATOR
Intervention: (-)-alpha-bisabolol
Number of subjects: 4
Study 16918613 — intervention group
Group type: COMPARATOR
Intervention: Canola oil
Number of subjects: 4
Study 15329377 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnet attachment
Number of subjects: 18
Study 15329377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball attachment
Number of subjects: 18
Study 15329377 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar-clip attachment
Number of subjects: 18
Study 15329377 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant treatment (all attachments)
Number of subjects: 18
Study 11780380 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEPe at 90% of PEEPi, stz
Number of subjects: 10
Study 11780380 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEPe at 100% of PEEPi, stz
Number of subjects: 10
Study 11780380 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEPe at 80% of PEEPi, stz
Number of subjects: 10
Study 9531224 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial intravenous heparin dose of 30,000 U/24 h
Number of subjects: 0
Study 9531224 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic activated partial thromboplastin time (APTT) achieved by 24 hours
Number of subjects: 0
Study 9531224 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtherapeutic heparin for 24 hours
Number of subjects: 0
Study 8438978 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatwell intervention
Number of subjects: 13
Study 8438978 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 companies)
Number of subjects: 13
Study 3641900 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold sitz baths
Number of subjects: 40
Study 3641900 — intervention group
Group type: COMPARATOR
Intervention: Warm sitz baths
Number of subjects: 40
Study 27401241 — intervention group
Group type: EXPERIMENTAL
Intervention: Positivity & Rules Program (PR program)
Number of subjects: 114
Study 27401241 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study 28185668 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide transnasal nebulization (group A)
Number of subjects: 30
Study 28185668 — intervention group
Group type: COMPARATOR
Intervention: Topical nasal steroids (group B)
Number of subjects: 30
Study 26386293 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician referral
Number of subjects: 1650
Study 26386293 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio ads
Number of subjects: 1650
Study 26386293 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet
Number of subjects: 1650
Study 26386293 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancillary Clinical Research Scientist Training (CREST) sites
Number of subjects: 1650
Study 24456363 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean red ginseng (5 g/day)
Number of subjects: 41
Study 24456363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 22340317 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulated interlocking anatomical femoral intramedullary nails (Group I)
Number of subjects: 152
Study 22340317 — intervention group
Group type: COMPARATOR
Intervention: Cannulated interlocking anatomical femoral intramedullary nails with tail wires (Group II)
Number of subjects: 152
Study 19637777 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple regimen with vitamin C (20 mg Omeprazol, 1 g amoxicillin, 250 mg clarithromycin plus 250 mg vitamin C twice daily for 2 weeks)
Number of subjects: 214
Study 19637777 — intervention group
Group type: COMPARATOR
Intervention: Triple regimen without vitamin C (20 mg Omeprazol, 1 g amoxicillin, and 500 mg clarithromycin twice daily for 2 weeks)
Number of subjects: 214
Study 17605895 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg daily) and vitamin B complex for 3 months
Number of subjects: 121
Study 17605895 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 121
Study 16355501 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg alendronate daily
Number of subjects: 148
Study 16355501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 12010109 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy (18 Gy of gamma radiation delivered to the target site 2 mm from an iridium‐192 source axis)
Number of subjects: 9
Study 12010109 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 9
Study 10468231 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiral computed tomography imaging
Number of subjects: 6
Study 7541210 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphoramidon (NEP inhibitor)
Number of subjects: 12
Study 7541210 — intervention group
Group type: COMPARATOR
Intervention: Captopril (ACE inhibitor)
Number of subjects: 12
Study 2090157 — intervention group
Group type: EXPERIMENTAL
Intervention: C31G 0.5%
Number of subjects: 12
Study 2090157 — intervention group
Group type: EXPERIMENTAL
Intervention: C31G 0.2%
Number of subjects: 12
Study 2090157 — intervention group
Group type: EXPERIMENTAL
Intervention: C31G 0.1%
Number of subjects: 12
Study 2090157 — intervention group
Group type: EXPERIMENTAL
Intervention: C31G 0.05%
Number of subjects: 12
Study 2090157 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine
Number of subjects: 12
Study 2090157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 386192 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 20
Study 386192 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 20
Study 30192390 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc
Number of subjects: 541
Study 28256912 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video about reproductive health and infertility (intervention group)
Number of subjects: 173
Study 28256912 — intervention group
Group type: COMPARATOR
Intervention: No exposure to educational video (control group)
Number of subjects: 173
Study 26122088 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive movement and active exercise from experienced physiotherapists, 3 times a week for 12 weeks
Number of subjects: 147
Study 26122088 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive movement and active exercise from parents or caregivers at home, 3 times a week for 12 weeks
Number of subjects: 147
Study 26122088 — intervention group
Group type: COMPARATOR
Intervention: Follow up only (control group)
Number of subjects: 147
Study 24246378 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine
Number of subjects: 458
Study 24246378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study 20490798 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg/m²/day administered 30 min prior to etoposide infusion
Number of subjects: 67
Study 20490798 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide and carboplatin infusions
Number of subjects: 67
Study 20490798 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A and MDR1 SNPs
Number of subjects: 67
Study 19238360 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (49 patients)
Number of subjects: 100
Study 19238360 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment (46 patients)
Number of subjects: 100
Study 19238360 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of DVT
Number of subjects: 100
Study 16635659 — intervention group
Group type: EXPERIMENTAL
Intervention: Active photopheresis
Number of subjects: 64
Study 16635659 — intervention group
Group type: COMPARATOR
Intervention: Sham photopheresis
Number of subjects: 64
Study 14646349 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib mesylate (STI571)
Number of subjects: 0
Study 14646349 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CD20 (rituximab)
Number of subjects: 0
Study 14646349 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic trioxide and all‐TRANS‐retinoic acid (ATRA)
Number of subjects: 0
Study 14646349 — intervention group
Group type: EXPERIMENTAL
Intervention: R-etodolac
Number of subjects: 0
Study 11436877 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocervical application of 0.5 mg dinoprostone gel (2 times during an interval of 4 hours) and intramuscular Prostin 15 M (Carboprost Tromethamine) (1 ml/h) administered 6 hours after the second application until abortion
Number of subjects: 97
Study 11436877 — intervention group
Group type: COMPARATOR
Intervention: Singleton endocervical application of 0.5 mg dinoprostone gel and intramuscular Prostin 15 M (Carboprost Tromethamine) (1 ml/2 h) administered 10 hours later until abortion
Number of subjects: 97
Study 11436877 — intervention group
Group type: EXPERIMENTAL
Intervention: Singleton double-dose endocervical application of 0.5 mg dinoprostone gel and intramuscular Prostin 15 M (Carboprost Tromethamine) (1 ml/2 h) administered 10 hours later until abortion
Number of subjects: 97
Study 9924227 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site prothrombin time using CoaguChek-Plus monitor in group A
Number of subjects: 62
Study 9924227 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site prothrombin time using CoaguChek-Plus monitor in group B
Number of subjects: 62
Study 9924227 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site prothrombin time using CoaguChek-Plus monitor in group C
Number of subjects: 62
Study 7801066 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemiparetic patients
Number of subjects: 35
Study 7801066 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 35
Study 7801066 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemiparetic patients
Number of subjects: 35
Study 7801066 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hemiparetic patients
Number of subjects: 35
Study 2809562 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 128
Study 2809562 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 128
Study 2809562 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 128
Study 2809562 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of terbutaline and ipratropium
Number of subjects: 128
Study 2809562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 972328 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral electric therapy (electrosleep)
Number of subjects: 0
Study 972328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30217471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened beverage (SSB)
Number of subjects: 28
Study 30217471 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 28
Study 28582355 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive group psychotherapy and motivational interviewing
Number of subjects: 36
Study 25277789 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol sublingually after delivery of the newborn
Number of subjects: 396
Study 25277789 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo sublingually after delivery of the newborn
Number of subjects: 396
Study 22385133 — intervention group
Group type: EXPERIMENTAL
Intervention: DAG meal (10 g of DAG oil)
Number of subjects: 41
Study 22385133 — intervention group
Group type: COMPARATOR
Intervention: TAG meal (TAG oil)
Number of subjects: 41
Study 20664016 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 110
Study 20664016 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diabetes development)
Number of subjects: 110
Study 18550968 — intervention group
Group type: EXPERIMENTAL
Intervention: Skill-based conditioning games
Number of subjects: 25
Study 18550968 — intervention group
Group type: COMPARATOR
Intervention: Instructional training
Number of subjects: 25
Study 15719076 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete dentures with clinical remount procedure
Number of subjects: 100
Study 15719076 — intervention group
Group type: COMPARATOR
Intervention: Complete dentures without clinical remount procedure
Number of subjects: 100
Study 12439805 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (300 mg) plus Lamivudine (150 mg) twice daily from week 34 of gestation until labor; during labor, zidovudine and lamivudine were given every 3 hours.
Number of subjects: 106
Study 10353554 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 40
Study 10353554 — intervention group
Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 40
Study 7556988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (25 mg/kg body weight for 12 months)
Number of subjects: 56
Study 7556988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 56
Study 7556988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 2025309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen and Alprazolam
Number of subjects: 78
Study 2025309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 7100263 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromperidol
Number of subjects: 23
Study 7100263 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 23
Study 31512457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethibond sutures (USP 5) with 4 threads (Group A)
Number of subjects: 40
Study 31512457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethibond sutures (USP 5) with 8 threads (Group B)
Number of subjects: 40
Study 31512457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrabraid sutures (USP 2) with 4 threads (Group C)
Number of subjects: 40
Study 31512457 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrabraid sutures (USP 2) with 8 threads (Group D)
Number of subjects: 40
Study 28738376 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation plus cognitive training
Number of subjects: 34
Study 28738376 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary rehabilitation alone
Number of subjects: 34
Study 25483291 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000mg twice daily
Number of subjects: 100
Study 25483291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23852610 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose prasugrel (5 mg/d)
Number of subjects: 2083
Study 23852610 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/d)
Number of subjects: 2083
Study 21883499 — intervention group
Group type: EXPERIMENTAL
Intervention: 1A/1B (alternate feeding of 1-day diet A followed by 1-day diet B)
Number of subjects: 135
Study 21883499 — intervention group
Group type: EXPERIMENTAL
Intervention: 1A/1C (alternate feeding of 1-day diet A followed by 1-day diet C)
Number of subjects: 135
Study 21883499 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly defined in the abstract)
Number of subjects: 135
Study 21883499 — intervention group
Group type: EXPERIMENTAL
Intervention: 1A/1B and 1A/1C
Number of subjects: 135
Study 19208305 — intervention group
Group type: EXPERIMENTAL
Intervention: Active depressor treatment with lisinopril or labetalol
Number of subjects: 180
Study 19208305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 19208305 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 180
Study 19208305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressor arm (not specified treatment)
Number of subjects: 180
Study 17558683 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose gonadotropin-releasing hormone agonist (buserelin)
Number of subjects: 12
Study 17558683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16534680 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation plus partial splenic embolization (EVL + PSE)
Number of subjects: 84
Study 16534680 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation alone (EVL)
Number of subjects: 84
Study 12492458 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg day(-1) for 4 weeks
Number of subjects: 17
Study 12492458 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg day(-1) for 12 weeks
Number of subjects: 17
Study 12492458 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 17
Study 12462824 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT)
Number of subjects: 11
Study 12462824 — intervention group
Group type: COMPARATOR
Intervention: Mimic therapeutic touch (placebo)
Number of subjects: 11
Study 8856491 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 65
Study 8856491 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 65
Study 1303630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg administered 6-hourly
Number of subjects: 0
Study 1303630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6372930 — intervention group
Group type: EXPERIMENTAL
Intervention: misonidazole
Number of subjects: 153
Study 31658994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab with concurrent stereotactic radiation therapy (50 Gy in 4 fractions or 60 Gy in 10 fractions)
Number of subjects: 106
Study 31658994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab with sequential stereotactic radiation therapy
Number of subjects: 106
Study 31658994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab with concurrent stereotactic radiation therapy
Number of subjects: 106